S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LCTX Lineage Cell Therapeutics Inc

0.5623

-0.0263 (-4.47%)

Last Updated: 05:55:07

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics Inc News

Form PRE 14A - Other preliminary proxy statements
Saturday 30 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 27 November 2024 (7 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 23 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 22 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
Friday 22 November 2024 (2 weeks ago) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 22 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Thursday 21 November 2024 (2 weeks ago) • Business Wire

Form 8-K - Current report
Friday 15 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Friday 15 November 2024 (3 weeks ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (4 weeks ago) • Edgar (US Regulatory)

More Lineage Cell Therapeutics Inc News Articles

BMO Global Dividend Oppo...

Glass House Brands

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions